Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
Multiple sclerosis is a chronic, inflammatory, demyelinating and neurodegenerative disease of the central nervous system. The etiology is unknown, and it is estimated that about 2.5 million people all around the world are suffering from this disease. It is the most common cause of non-traumatic disa...
Main Authors: | Ivanović Jovana, Pekmezović Tatjana, Drulović Jelena |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Belgrade, Medical Faculty
2019-01-01
|
Series: | Medicinski Podmladak |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2019/0369-15271901053I.pdf |
Similar Items
-
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
by: Elmazny A, et al.
Published: (2020-03-01) -
Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01) -
Investigating the Occurrence of Femoral Head Avascular Necrosis in Patient with Multiple Sclerosis Treated with Interferon-Beta
by: Pegah Sadat Fatehi, et al.
Published: (2018-11-01) -
Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01) -
Fingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
by: Masoud Etemadifar, et al.
Published: (2017-02-01)